- Home
- AUNA vs TRDA Comparison
AUNA vs TRDA Comparison
Compare AUNA & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUNA
- TRDA
- Stock Information
- Founded
- AUNA 1989
- TRDA 2016
- Country
- AUNA Luxembourg
- TRDA United States
- Employees
- AUNA N/A
- TRDA N/A
- Industry
- AUNA
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- AUNA
- TRDA Health Care
- Exchange
- AUNA NYSE
- TRDA Nasdaq
- Market Cap
- AUNA 521.9M
- TRDA 548.2M
- IPO Year
- AUNA 2024
- TRDA 2021
- Fundamental
- Price
- AUNA $7.77
- TRDA $12.49
- Analyst Decision
- AUNA Strong Buy
- TRDA Strong Buy
- Analyst Count
- AUNA 4
- TRDA 3
- Target Price
- AUNA $13.40
- TRDA $25.67
- AVG Volume (30 Days)
- AUNA 42.3K
- TRDA 116.2K
- Earning Date
- AUNA 11-19-2024
- TRDA 03-12-2025
- Dividend Yield
- AUNA N/A
- TRDA N/A
- EPS Growth
- AUNA N/A
- TRDA N/A
- EPS
- AUNA N/A
- TRDA 1.55
- Revenue
- AUNA $1,168,151,825.00
- TRDA $215,232,000.00
- Revenue This Year
- AUNA $17.06
- TRDA $47.45
- Revenue Next Year
- AUNA $9.63
- TRDA N/A
- P/E Ratio
- AUNA N/A
- TRDA $8.07
- Revenue Growth
- AUNA 18.72
- TRDA 146.92
- 52 Week Low
- AUNA $6.17
- TRDA $11.35
- 52 Week High
- AUNA $10.85
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- AUNA N/A
- TRDA 21.47
- Support Level
- AUNA N/A
- TRDA $17.13
- Resistance Level
- AUNA N/A
- TRDA $18.76
- Average True Range (ATR)
- AUNA 0.00
- TRDA 0.95
- MACD
- AUNA 0.00
- TRDA -0.52
- Stochastic Oscillator
- AUNA 0.00
- TRDA 2.24
About AUNA AUNA S A
Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru, Healthcare services in Peru, Healthcare services in Colombia, and Healthcare services in Mexico. Key revenue is generated from Peru.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.